カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のレナリドマイド薬市場予測2023-2029：5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル

【英語タイトル】Lenalidomide Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8542）・商品コード：MMG23LY8542
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：72
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のレナリドマイド薬市場規模と予測を収録しています。・世界のレナリドマイド薬市場：売上、2018年-2023年、2024年-2029年
・世界のレナリドマイド薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のレナリドマイド薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「5mgカプセル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

レナリドマイド薬のグローバル主要企業は、Celgene、 Exovaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、レナリドマイド薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のレナリドマイド薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のレナリドマイド薬市場：タイプ別市場シェア、2022年
・5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル

世界のレナリドマイド薬市場：用途別、2018年-2023年、2024年-2029年
世界のレナリドマイド薬市場：用途別市場シェア、2022年
・多発性骨髄腫（MM）、骨髄異形成症候群（MDS）、その他

世界のレナリドマイド薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のレナリドマイド薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるレナリドマイド薬のグローバル売上、2018年-2023年
・主要企業におけるレナリドマイド薬のグローバル売上シェア、2022年
・主要企業におけるレナリドマイド薬のグローバル販売量、2018年-2023年
・主要企業におけるレナリドマイド薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Celgene、 Exova

*************************************************************

・調査・分析レポートの概要
レナリドマイド薬市場の定義
市場セグメント
世界のレナリドマイド薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のレナリドマイド薬市場規模
世界のレナリドマイド薬市場規模：2022年 VS 2029年
世界のレナリドマイド薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのレナリドマイド薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のレナリドマイド薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル
レナリドマイド薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：多発性骨髄腫（MM）、骨髄異形成症候群（MDS）、その他
レナリドマイド薬の用途別グローバル売上・予測

・地域別市場分析
地域別レナリドマイド薬市場規模 2022年と2029年
地域別レナリドマイド薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Celgene、 Exova
...

It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS).
This report aims to provide a comprehensive presentation of the global market for Lenalidomide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lenalidomide Drug. This report contains market size and forecasts of Lenalidomide Drug in global, including the following market information:
Global Lenalidomide Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Lenalidomide Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Lenalidomide Drug companies in 2022 (%)
The global Lenalidomide Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
5 mg Capsules Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lenalidomide Drug include Celgene and Exova etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lenalidomide Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lenalidomide Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lenalidomide Drug Market Segment Percentages, by Type, 2022 (%)
5 mg Capsules
10 mg Capsules
15 mg Capsules
25 mg Capsules
Global Lenalidomide Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lenalidomide Drug Market Segment Percentages, by Application, 2022 (%)
Multiple myeloma (MM)
Myelodysplastic syndromes (MDS)
Other
Global Lenalidomide Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lenalidomide Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lenalidomide Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Lenalidomide Drug revenues share in global market, 2022 (%)
Key companies Lenalidomide Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Lenalidomide Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celgene
Exova
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lenalidomide Drug, market overview.
Chapter 2: Global Lenalidomide Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Lenalidomide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lenalidomide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lenalidomide Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Lenalidomide Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lenalidomide Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lenalidomide Drug Overall Market Size
2.1 Global Lenalidomide Drug Market Size: 2022 VS 2029
2.2 Global Lenalidomide Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Lenalidomide Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Lenalidomide Drug Players in Global Market
3.2 Top Global Lenalidomide Drug Companies Ranked by Revenue
3.3 Global Lenalidomide Drug Revenue by Companies
3.4 Global Lenalidomide Drug Sales by Companies
3.5 Global Lenalidomide Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Lenalidomide Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Lenalidomide Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lenalidomide Drug Players in Global Market
3.8.1 List of Global Tier 1 Lenalidomide Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Lenalidomide Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Lenalidomide Drug Market Size Markets, 2022 & 2029
4.1.2 5 mg Capsules
4.1.3 10 mg Capsules
4.1.4 15 mg Capsules
4.1.5 25 mg Capsules
4.2 By Type – Global Lenalidomide Drug Revenue & Forecasts
4.2.1 By Type – Global Lenalidomide Drug Revenue, 2018-2023
4.2.2 By Type – Global Lenalidomide Drug Revenue, 2024-2029
4.2.3 By Type – Global Lenalidomide Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Lenalidomide Drug Sales & Forecasts
4.3.1 By Type – Global Lenalidomide Drug Sales, 2018-2023
4.3.2 By Type – Global Lenalidomide Drug Sales, 2024-2029
4.3.3 By Type – Global Lenalidomide Drug Sales Market Share, 2018-2029
4.4 By Type – Global Lenalidomide Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Lenalidomide Drug Market Size, 2022 & 2029
5.1.2 Multiple myeloma (MM)
5.1.3 Myelodysplastic syndromes (MDS)
5.1.4 Other
5.2 By Application – Global Lenalidomide Drug Revenue & Forecasts
5.2.1 By Application – Global Lenalidomide Drug Revenue, 2018-2023
5.2.2 By Application – Global Lenalidomide Drug Revenue, 2024-2029
5.2.3 By Application – Global Lenalidomide Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Lenalidomide Drug Sales & Forecasts
5.3.1 By Application – Global Lenalidomide Drug Sales, 2018-2023
5.3.2 By Application – Global Lenalidomide Drug Sales, 2024-2029
5.3.3 By Application – Global Lenalidomide Drug Sales Market Share, 2018-2029
5.4 By Application – Global Lenalidomide Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Lenalidomide Drug Market Size, 2022 & 2029
6.2 By Region – Global Lenalidomide Drug Revenue & Forecasts
6.2.1 By Region – Global Lenalidomide Drug Revenue, 2018-2023
6.2.2 By Region – Global Lenalidomide Drug Revenue, 2024-2029
6.2.3 By Region – Global Lenalidomide Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Lenalidomide Drug Sales & Forecasts
6.3.1 By Region – Global Lenalidomide Drug Sales, 2018-2023
6.3.2 By Region – Global Lenalidomide Drug Sales, 2024-2029
6.3.3 By Region – Global Lenalidomide Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Lenalidomide Drug Revenue, 2018-2029
6.4.2 By Country – North America Lenalidomide Drug Sales, 2018-2029
6.4.3 US Lenalidomide Drug Market Size, 2018-2029
6.4.4 Canada Lenalidomide Drug Market Size, 2018-2029
6.4.5 Mexico Lenalidomide Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Lenalidomide Drug Revenue, 2018-2029
6.5.2 By Country – Europe Lenalidomide Drug Sales, 2018-2029
6.5.3 Germany Lenalidomide Drug Market Size, 2018-2029
6.5.4 France Lenalidomide Drug Market Size, 2018-2029
6.5.5 U.K. Lenalidomide Drug Market Size, 2018-2029
6.5.6 Italy Lenalidomide Drug Market Size, 2018-2029
6.5.7 Russia Lenalidomide Drug Market Size, 2018-2029
6.5.8 Nordic Countries Lenalidomide Drug Market Size, 2018-2029
6.5.9 Benelux Lenalidomide Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Lenalidomide Drug Revenue, 2018-2029
6.6.2 By Region – Asia Lenalidomide Drug Sales, 2018-2029
6.6.3 China Lenalidomide Drug Market Size, 2018-2029
6.6.4 Japan Lenalidomide Drug Market Size, 2018-2029
6.6.5 South Korea Lenalidomide Drug Market Size, 2018-2029
6.6.6 Southeast Asia Lenalidomide Drug Market Size, 2018-2029
6.6.7 India Lenalidomide Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Lenalidomide Drug Revenue, 2018-2029
6.7.2 By Country – South America Lenalidomide Drug Sales, 2018-2029
6.7.3 Brazil Lenalidomide Drug Market Size, 2018-2029
6.7.4 Argentina Lenalidomide Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Lenalidomide Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Lenalidomide Drug Sales, 2018-2029
6.8.3 Turkey Lenalidomide Drug Market Size, 2018-2029
6.8.4 Israel Lenalidomide Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Lenalidomide Drug Market Size, 2018-2029
6.8.6 UAE Lenalidomide Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Celgene
7.1.1 Celgene Company Summary
7.1.2 Celgene Business Overview
7.1.3 Celgene Lenalidomide Drug Major Product Offerings
7.1.4 Celgene Lenalidomide Drug Sales and Revenue in Global (2018-2023)
7.1.5 Celgene Key News & Latest Developments
7.2 Exova
7.2.1 Exova Company Summary
7.2.2 Exova Business Overview
7.2.3 Exova Lenalidomide Drug Major Product Offerings
7.2.4 Exova Lenalidomide Drug Sales and Revenue in Global (2018-2023)
7.2.5 Exova Key News & Latest Developments
8 Global Lenalidomide Drug Production Capacity, Analysis
8.1 Global Lenalidomide Drug Production Capacity, 2018-2029
8.2 Lenalidomide Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Lenalidomide Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lenalidomide Drug Supply Chain Analysis
10.1 Lenalidomide Drug Industry Value Chain
10.2 Lenalidomide Drug Upstream Market
10.3 Lenalidomide Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lenalidomide Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Lenalidomide Drug in Global Market
Table 2. Top Lenalidomide Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Lenalidomide Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Lenalidomide Drug Revenue Share by Companies, 2018-2023
Table 5. Global Lenalidomide Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Lenalidomide Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Lenalidomide Drug Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Lenalidomide Drug Product Type
Table 9. List of Global Tier 1 Lenalidomide Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lenalidomide Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Lenalidomide Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Lenalidomide Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Lenalidomide Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Lenalidomide Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Lenalidomide Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Lenalidomide Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Lenalidomide Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Lenalidomide Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Lenalidomide Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Lenalidomide Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Lenalidomide Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Lenalidomide Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Lenalidomide Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Lenalidomide Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Lenalidomide Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Lenalidomide Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Lenalidomide Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Lenalidomide Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Lenalidomide Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Lenalidomide Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Lenalidomide Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Lenalidomide Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Lenalidomide Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Lenalidomide Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Lenalidomide Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Lenalidomide Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Lenalidomide Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Lenalidomide Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Lenalidomide Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Lenalidomide Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Lenalidomide Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Lenalidomide Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Lenalidomide Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Lenalidomide Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Lenalidomide Drug Sales, (K Units), 2024-2029
Table 46. Celgene Company Summary
Table 47. Celgene Lenalidomide Drug Product Offerings
Table 48. Celgene Lenalidomide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Celgene Key News & Latest Developments
Table 50. Exova Company Summary
Table 51. Exova Lenalidomide Drug Product Offerings
Table 52. Exova Lenalidomide Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Exova Key News & Latest Developments
Table 54. Lenalidomide Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 55. Global Lenalidomide Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Lenalidomide Drug Production by Region, 2018-2023 (K Units)
Table 57. Global Lenalidomide Drug Production by Region, 2024-2029 (K Units)
Table 58. Lenalidomide Drug Market Opportunities & Trends in Global Market
Table 59. Lenalidomide Drug Market Drivers in Global Market
Table 60. Lenalidomide Drug Market Restraints in Global Market
Table 61. Lenalidomide Drug Raw Materials
Table 62. Lenalidomide Drug Raw Materials Suppliers in Global Market
Table 63. Typical Lenalidomide Drug Downstream
Table 64. Lenalidomide Drug Downstream Clients in Global Market
Table 65. Lenalidomide Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Lenalidomide Drug Segment by Type in 2022
Figure 2. Lenalidomide Drug Segment by Application in 2022
Figure 3. Global Lenalidomide Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lenalidomide Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Lenalidomide Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Lenalidomide Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Lenalidomide Drug Revenue in 2022
Figure 9. By Type - Global Lenalidomide Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Lenalidomide Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Lenalidomide Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Lenalidomide Drug Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Lenalidomide Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Lenalidomide Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Lenalidomide Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Lenalidomide Drug Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Lenalidomide Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Lenalidomide Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Lenalidomide Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Lenalidomide Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Lenalidomide Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Lenalidomide Drug Sales Market Share, 2018-2029
Figure 23. US Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Lenalidomide Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Lenalidomide Drug Sales Market Share, 2018-2029
Figure 28. Germany Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Lenalidomide Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Lenalidomide Drug Sales Market Share, 2018-2029
Figure 37. China Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Lenalidomide Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Lenalidomide Drug Sales Market Share, 2018-2029
Figure 44. Brazil Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Lenalidomide Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Lenalidomide Drug Sales Market Share, 2018-2029
Figure 48. Turkey Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Lenalidomide Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Lenalidomide Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Lenalidomide Drug by Region, 2022 VS 2029
Figure 54. Lenalidomide Drug Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のレナリドマイド薬市場予測2023-2029：5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル] (コード：MMG23LY8542)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のレナリドマイド薬市場予測2023-2029：5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のソリリス薬市場予測2023-2029：血漿交換、血漿注入
  • 世界のレブラミド市場予測2023-2029：10mg、25mg、その他
  • 世界の心臓用薬剤コーティングバルーン市場予測2023-2029：パクリタキセルコーティング型、その他コーティング型
  • 世界のピモジド抗精神病薬市場予測2023-2029：1Mg、2Mg、4Mg
  • 世界の冠動脈疾患用薬剤コーティングバルーン市場予測2023-2029：パクリタキセルコーティング、その他コーティング

    • ◆H&Iグローバルリサーチのお客様（例）◆